Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Hofmann

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|December 17, 2024
From Crisis to Complications: A Nationwide Cohort Study Assessing One-Year Cardiovascular and Thromboembolic Risks After Severe COVID-19 Compared to Matched ControlsAndreas Liliequist, Per Svensson, Robin Hofmann, et al.
Journal of the American Heart Association|May 18, 2024
Trends in Survival After First Myocardial Infarction in People With DiabetesLinn Glynn, Marcus Lind, Tomas Andersson, et al.
Journal of the American College of Emergency Physicians Open|July 10, 2023
Socioeconomic status is associated with process times in the emergency department for patients with chest painSebastian Herlitz, Joel Ohm, Henrike Häbel, et al.
European Heart Journal Open|June 2, 2023
Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint studySophia Humphries, Katarina Mars, Robin Hofmann, et al.
Scientific Reports|November 25, 2025
Psychometric properties of the Swedish cardiac anxiety questionnaire: a Rasch analysisPhilip Leissner, Magnus Johansson, Katarina Mars, et al.
Heart (British Cardiac Society)|March 31, 2018
Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trialsNariman Sepehrvand, Stefan K James, Dion Stub, et al.
European Heart Journal. Acute Cardiovascular Care|May 5, 2022
Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked studySophia Humphries, John Wallert, Katarina Mars, et al.
Lakartidningen|January 21, 2021
[Focus on individualized therapy for patients with acute coronary syndrome without persistent ST-segment elevation]Anna Holm, Kasper Andersen, Moa Simonsson, et al.
Scientific Reports|July 15, 2022
Immigrant background and socioeconomic status are associated with severe COVID-19 requiring intensive carePer Nordberg, Martin Jonsson, Jacob Hollenberg, et al.
General Hospital Psychiatry|February 21, 2025
A randomized controlled trial of beta-blockers effects on cardiac anxietyPhilip Leissner, Katarina Mars, Sophia Humphries, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|December 17, 2024
From Crisis to Complications: A Nationwide Cohort Study Assessing One-Year Cardiovascular and Thromboembolic Risks After Severe COVID-19 Compared to Matched ControlsAndreas Liliequist, Per Svensson, Robin Hofmann, et al.
Journal of the American Heart Association|May 18, 2024
Trends in Survival After First Myocardial Infarction in People With DiabetesLinn Glynn, Marcus Lind, Tomas Andersson, et al.
Journal of the American College of Emergency Physicians Open|July 10, 2023
Socioeconomic status is associated with process times in the emergency department for patients with chest painSebastian Herlitz, Joel Ohm, Henrike Häbel, et al.
European Heart Journal Open|June 2, 2023
Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint studySophia Humphries, Katarina Mars, Robin Hofmann, et al.
Scientific Reports|November 25, 2025
Psychometric properties of the Swedish cardiac anxiety questionnaire: a Rasch analysisPhilip Leissner, Magnus Johansson, Katarina Mars, et al.
Heart (British Cardiac Society)|March 31, 2018
Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trialsNariman Sepehrvand, Stefan K James, Dion Stub, et al.
European Heart Journal. Acute Cardiovascular Care|May 5, 2022
Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked studySophia Humphries, John Wallert, Katarina Mars, et al.
Lakartidningen|January 21, 2021
[Focus on individualized therapy for patients with acute coronary syndrome without persistent ST-segment elevation]Anna Holm, Kasper Andersen, Moa Simonsson, et al.
Scientific Reports|July 15, 2022
Immigrant background and socioeconomic status are associated with severe COVID-19 requiring intensive carePer Nordberg, Martin Jonsson, Jacob Hollenberg, et al.
General Hospital Psychiatry|February 21, 2025
A randomized controlled trial of beta-blockers effects on cardiac anxietyPhilip Leissner, Katarina Mars, Sophia Humphries, et al.
Pageof 8